Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy.
Botton T; Yeh I; Nelson T; Vemula SS; Sparatta A; Garrido MC; Allegra M; Rocchi S; Bahadoran P; McCalmont TH; LeBoit PE; Burton EA; Bollag G; Ballotti R; Bastian BC; Pigment Cell & Melanoma Research, 2013, vol. 26, issue 6, p 845, ISSN 1755148x. ISBN 1755148x.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef